Korean Journal of Exercise Nutrition (운동영양학회지)

한국운동영양학회
권호 표지
DOI QR코드

DOI QR Code

The effects of royal jelly protein on bone mineral density and strength in ovariectomized female rats

  • Hattori, Satoshi (Faculty of Health and Sport Sciences, University of Tsukuba) ;
  • Omi, Naomi (Faculty of Health and Sport Sciences, University of Tsukuba)
  • Received : 2021.06.12
  • Accepted : 2021.06.29
  • Published : 2021.06.30
⟨ Previous Next ⟩

Abstract

[Purpose] Sex hormones deficiency leads to dramatically bone loss in particular postmenopausal women. Royal jelly has anti-osteoporosis effect due to maintain bone volume in that condition. We hypothesized that royal jelly protein (RJP, a latent residue after extracting royal jelly) also prevents bone deficient in ovariectomized (OVX) female rats, the animal model of postmenopausal women. [Methods] Female Sprague-Dawley rats (n = 30, 6 weeks age old) were sham operated (Sham; sham operated group, n = 7), OVX control group (OC, n = 7), OVX with low RJP intake group (ORL, n = 8), and OVX with high RJP intake group (ORH, n = 8) during 8 weeks experimental periods. In the end point of this experiment, the bone samples (lumbar spine, tibia, and femur) were surgically removed under anesthesia. These bone samples were evaluated bone mineral density (BMD) and bone strength. [Results] BMD of lumbar spine in RJP intake groups (ORL, ORH) were higher than that in OC group (p < 0.05 and p < 0.01) in RJP intake volume dependent manner. BMD of tibial proximal metaphysis and diaphysis in RJP intake groups were also higher than these in OC group (p < 0.01 and p < 0.01 / p < 0.05 and p < 0.001). In addition, breaking force of femur in RJP intake groups were significantly increase compared with that in OC group (p < 0.001 respectively). [Conclusion] These findings indicate that RJP contribute to prevent sex hormone related bone abnormality.

Keywords

Acknowledgement

We would like to thank members of exercise and nutrition laboratory in University of Tsukuba for useful discussions and supports.

References

  1. Langdahl B, Ferrari S, Dempster DW. Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. Ther Adv Musculoskelet Dis. 2016;8:225-35. https://doi.org/10.1177/1759720X16670154
  2. Tabatabai LS, Sellmeyer DE. Nutritional supplements and skeletal health. Curr Osteoporos Rep. 2021;19:23-33. https://doi.org/10.1007/s11914-020-00651-x
  3. Lerner UH. Bone remodeling in post-menopausal osteoporosis. J Dent Res. 2006;85:584-95. https://doi.org/10.1177/154405910608500703
  4. Bellavia D, Dimarco E, Costa V, Carina V, De Luca A, Raimondi L, Fini M, Gentile C, Caradonna F, Giavaresi G. Flavonoids in bone erosive diseases: perspectives in osteoporosis treatment. Trends Endocrinol Metab. 2021;32:76-94. https://doi.org/10.1016/j.tem.2020.11.007
  5. Hattori S, Park S, Park JH, Omi N. The effect of dehydroepiandrosterone administration on intestinal calcium absorption in ovariectomized female rats. Phys Act Nutr. 2020;24:24-7. https://doi.org/10.20463/pan.2020.0005
  6. Chen LR, Ko NY, Chen KH. Medical treatment for osteoporosis: from molecular to clinical opinions. Int J Mol Sci. 2019;20:1-21. https://doi.org/10.3390/ijms20010001
  7. Pasupuleti VR, Sammugam L, Ramesh N, Gan SH. Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits. Oxid Med Cell Longev. 2017;2017:1259510.
  8. Cornara L, Biagi M, Xiao J, Burlando B. Therapeutic properties of bioactive compounds from different honeybee products. Front Pharmacol. 2017;8:412. https://doi.org/10.3389/fphar.2017.00412
  9. Tsuchiya Y, Hayashi M, Nagamatsu K, Ono T, Kamakura M, Iwata T, Nakashima T. The key royal jelly component 10-hydroxy-2-decenoic acid protects against bone loss by inhibiting NF-κB signaling downstream of FFAR4. J Biol Chem. 2020;295:12224-32. https://doi.org/10.1074/jbc.ra120.013821
  10. Matsui T, Yukiyoshi A, Doi S, Sugimoto H, Yamada H, Matsumoto K. Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. J Nutr Biochem. 2002;13:80-6. https://doi.org/10.1016/S0955-2863(01)00198-X
  11. Kaku M, Rocabado JMR, Kitami M, Ida T, Uoshima K. Royal jelly affects collagen crosslinking in bone of ovariectomized rats. J Funct Foods. 2014;7:398-406. https://doi.org/10.1016/j.jff.2014.01.019
  12. Hattori S, Park JH, Agata U, Akimoto T, Oda M, Higano M, Aikawa Y, Nabekura Y, Yamato H, Ezawa I, Omi N. Influence of food restriction combined with voluntary running on bone morphology and strength in male rats. Calcif Tissue Int. 2013;93:540-48. https://doi.org/10.1007/s00223-013-9787-6
  13. Hattori S, Agata U, Park J-H, Iimura Y, Tokuda S, Ezawa I, Omi N. The relationship between salivary calcium concentration and differences in bone mineral density level in female rats. J Nutr Sci Vitaminol. 2014;60:152-8. https://doi.org/10.3177/jnsv.60.152
  14. Narita Y, Nomura J, Ohta S, Inoh Y, Suzuki KM, Araki Y, Okada S, Matsumoto I, Isohama Y, Abe K, Miyata T, Mishima S. Royal jelly stimulates bone formation: physiologic and nutrigenomic studies with mice and cell lines. Biosci Biotechnol Biochem. 2006;70:2508-14. https://doi.org/10.1271/bbb.60240
  15. Wronski TJ, Dann LM, Horner SL. Time course of vertebral osteopenia in ovariectomized rats. Bone. 1989;10:295-301. https://doi.org/10.1016/8756-3282(89)90067-7
  16. Wronski TJ, Walsh CC, Ignaszewski LA. Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone. 1986;7:119-23. https://doi.org/10.1016/8756-3282(86)90683-6
  17. Garnero P. The contribution of collagen crosslinks to bone strength. Bonekey Rep. 2012;1:182. https://doi.org/10.1038/bonekey.2012.182
  18. Gertz BJ, Shao P, Hanson DA, Quan H, Harris ST, Genant HK, Chesnut CH 3rd, Eyre DR. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res. 1994;9:135-42. https://doi.org/10.1002/jbmr.5650090202
  19. Ott SM. Cortical or trabecular bone: what's the difference? Am J Nephrol. 2018;47:373-5. https://doi.org/10.1159/000489672